Table 7 (a) Correlations between \(\gamma_{mel}\) and clinical measures, with multiple potential values. (b) Correlations between \(\gamma_{mel}\) and binary covariates
From: Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm
(a) \(\gamma_{mel}\) and clinical measures | (b) \(\gamma_{mel}\) and binary covariates | |||
|---|---|---|---|---|
Biomarker | ROC AUC | Maximal Cohen’s kappa (κ) | Biomarker | Cohen’s kappa (κ) |
Age | 0.56 | 0.219 | Malignant melanoma status | 0.185 |
Breslow thickness | 0.63 | 0.304 | Nodular melanoma status | 0.258 |
LDH | 0.52 | 0.128 | BRAF V600 status | 0.124 |
LY% | 0.52 | 0.156 | ||
SOD at the baseline | 0.61 | 0.251 | ||